Literature DB >> 2705380

Usefulness of Doppler echocardiography in the diagnosis of congestive heart failure.

F V Aguirre1, A C Pearson, M K Lewen, M McCluskey, A J Labovitz.   

Abstract

One hundred fifty-one consecutive patients with a diagnosis of congestive heart failure (CHF) referred for echocardiography were prospectively evaluated to (1) define the frequency of normal left ventricular systolic function in a referral-based population with CHF; (2) establish cardiac mechanisms responsible for symptomatology in these patients; and (3) assess the ability to clinically differentiate these subsets of patients based on routine history and physical examination. Of the 151 total patients, 51 (34%) had normal left ventricular systolic function (left ventricular ejection fraction greater than or equal to 55%). Primary valvular disease was present in 4 of these 51 patients (8%), and Doppler echocardiographic evidence of abnormal left ventricular filling (diastolic dysfunction) was evident in 10 (20%). In addition, no predefined resting abnormality was noted in 34 (66%) of them. Despite this finding, 51% of all patients with normal left ventricular systolic function were being treated with digoxin therapy in the absence of atrial arrhythmia. Clinical differentiation of this group of patients from those with abnormal left ventricular systolic function was difficult and may have accounted for this apparently inappropriate treatment. Thus, evaluation of left ventricular function and of causative mechanisms of CHF before initiation of long-term treatment is mandatory.

Entities:  

Mesh:

Year:  1989        PMID: 2705380     DOI: 10.1016/0002-9149(89)90085-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

Review 1.  Central role of echocardiography in the diagnosis and assessment of heart failure. British Society of Echocardiography.

Authors:  M G Cheesman; G Leech; J Chambers; M J Monaghan; P Nihoyannopoulos
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

2.  Echocardiographic features and brain natriuretic peptides in patients presenting with heart failure and preserved systolic function.

Authors:  M D Thomas; K F Fox; D A Wood; J S R Gibbs; A J S Coats; M Y Henein; P A Poole-Wilson; G C Sutton
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

Review 3.  Digoxin or angiotensin converting enzyme inhibitors for congestive heart failure in geriatric patients. Which is the preferred treatment?

Authors:  W S Aronow
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

4.  Diagnosis of heart failure.

Authors:  J Cleland
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

Review 5.  Congestive heart failure arising from diastolic dysfunction in the presence of normal left-ventricular systolic function.

Authors:  R F Stainback
Journal:  Tex Heart Inst J       Date:  1999

Review 6.  Beta receptor antagonists in the treatment of heart failure.

Authors:  H Persson; L Erhardt
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

Review 7.  Postsurgical complications in older patients. The role of pharmacological intervention.

Authors:  G Zuccalà; A Cocchi; G Gambassi; R Bernabei; P Carbonin
Journal:  Drugs Aging       Date:  1994-12       Impact factor: 3.923

8.  Acute alterations of pre- and afterload: are Doppler-derived diastolic filling patterns able to differentiate the loading condition?

Authors:  H Völler; A Uhrig; C Spielberg; H von Ameln; K Schröder; T Brüggemann; R Schröder
Journal:  Int J Card Imaging       Date:  1993-12

9.  Stability of plasma concentrations of N and C terminal atrial natriuretic peptides at room temperature.

Authors:  J G Cleland; S Ward; D Dutka; F Habib; M Impallomeni; I J Morton
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

Review 10.  How well can the chest radiograph diagnose left ventricular dysfunction?

Authors:  R G Badgett; C D Mulrow; P M Otto; G Ramírez
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.